Matches in Wikidata for { <http://www.wikidata.org/entity/Q69657958> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q69657958 description "artículu científicu espublizáu en payares de 1986" @default.
- Q69657958 description "im November 1986 veröffentlichter wissenschaftlicher Artikel" @default.
- Q69657958 description "scientific article published on 01 November 1986" @default.
- Q69657958 description "wetenschappelijk artikel" @default.
- Q69657958 description "наукова стаття, опублікована в листопаді 1986" @default.
- Q69657958 description "գիտական հոդված հրատարակված 1986 թվականի նոյեմբերի 1-ին" @default.
- Q69657958 name "Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a" @default.
- Q69657958 name "Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a" @default.
- Q69657958 type Item @default.
- Q69657958 label "Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a" @default.
- Q69657958 label "Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a" @default.
- Q69657958 prefLabel "Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a" @default.
- Q69657958 prefLabel "Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a" @default.
- Q69657958 P1433 Q69657958-5D076F72-B9CA-41AF-B9EE-2BF614A77F18 @default.
- Q69657958 P1476 Q69657958-CD792523-600E-4D26-AFE6-72B627E22536 @default.
- Q69657958 P2093 Q69657958-1600C4AA-8E86-48E5-93F6-2BBDF93AF953 @default.
- Q69657958 P2093 Q69657958-2B5D18E0-F523-426D-A6C4-A60219E33869 @default.
- Q69657958 P2093 Q69657958-5BCC2807-B1F2-4DD1-878B-F0B18C46C2C8 @default.
- Q69657958 P2093 Q69657958-FA2E6B2B-2512-420F-A0BD-500E28F19D96 @default.
- Q69657958 P304 Q69657958-5F5D1776-F12D-4DD6-A29A-BA75371EA13D @default.
- Q69657958 P31 Q69657958-17664970-5FCD-40D9-AFED-3A49300D648C @default.
- Q69657958 P356 Q69657958-2D691A22-B3F5-4236-81ED-21881FC2029F @default.
- Q69657958 P433 Q69657958-66C58D69-F610-4129-858E-75C65980E4B7 @default.
- Q69657958 P478 Q69657958-4094AEED-B111-44B5-9FDE-4D8041BF9D8C @default.
- Q69657958 P577 Q69657958-52B25D53-E637-4EC8-9A25-B94AFA7A6968 @default.
- Q69657958 P698 Q69657958-6BC7A61A-C9E4-484A-8065-5B2389734E4E @default.
- Q69657958 P921 Q69657958-E61C97A1-43D8-40C6-9634-3F61D3DA2EFC @default.
- Q69657958 P356 ART.1780291103 @default.
- Q69657958 P698 3778540 @default.
- Q69657958 P1433 Q23929027 @default.
- Q69657958 P1476 "Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a" @default.
- Q69657958 P2093 "A S Townes" @default.
- Q69657958 P2093 "M A Cremer" @default.
- Q69657958 P2093 "P H Wooley" @default.
- Q69657958 P2093 "W C Watson" @default.
- Q69657958 P304 "1316-1321" @default.
- Q69657958 P31 Q13442814 @default.
- Q69657958 P356 "10.1002/ART.1780291103" @default.
- Q69657958 P433 "11" @default.
- Q69657958 P478 "29" @default.
- Q69657958 P577 "1986-11-01T00:00:00Z" @default.
- Q69657958 P698 "3778540" @default.
- Q69657958 P921 Q187255 @default.